Miriam Shatley, MD
Dermatology · Flowood, MSNPI 1235154121
Payments from drug & device makers
Across 490 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$1K
- Pfizer$801
- Lilly USA, LLC$545
- Johnson & Johnson$426
- Regeneron Healthcare Solutions, Inc.$426
- plus $3K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 133 | $2,368 |
| Novartis | 131 | $1,467 |
| Pfizer | 28 | $801 |
| Lilly USA, LLC | 30 | $545 |
| Johnson & Johnson | 14 | $426 |
| Regeneron Healthcare Solutions, Inc. | 17 | $426 |
| Incyte Corporation | 21 | $352 |
| Amgen | 18 | $346 |
| LEO Pharma Inc. | 16 | $321 |
| Sun Pharmaceutical Industries Inc. | 14 | $284 |
| Galderma Laboratories, L.p. | 9 | $271 |
| Almirall LLC | 10 | $225 |
| Sanofi | 8 | $191 |
| Merz North America, Inc. | 1 | $149 |
| Bristol Myers Squibb | 6 | $123 |
| Janssen Scientific Affairs, LLC | 1 | $119 |
| UCB, Inc. | 6 | $119 |
| Mallinckrodt Hospital Products Inc. | 4 | $106 |
| E.r. Squibb & Sons, L.L.C. | 2 | $79 |
| Hill Dermaceuticals, Inc. | 2 | $65 |
| Revance Therapeutics, Inc. | 1 | $62 |
| Mayne Pharma Commercial LLC | 4 | $52 |
| Regeneron | 1 | $45 |
| VYNE Pharmaceuticals Inc. | 2 | $45 |
| Dermira, Inc. | 2 | $34 |
| Genentech USA, Inc. | 2 | $29 |
| Biofrontera Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Organon | 1 | $21 |
| Dermavant Sciences, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $15 |
| Aclaris Therapeutics, Inc. | 1 | $15 |
How this compares
$9,169 in reported general payments places this provider in the 70th percentile of 78 dermatology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Flowood
- Amy FlischelFlowood$17K
- Anna AsherFlowood$9K
- William BurrowFlowood$8K
- Robert BurrowFlowood$5K
- Jeremy JacksonJackson$450K
- Jasmine HollingerRidgeland$373K
- Lindsey ZubritskyOcean Springs$349K
- Maureen OffiahHattiesburg$275K
- Lyndsay ShippOxford$246K
- Thy HuynhJackson$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.